Mark J. Foley Sells 31,279 Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC) Stock

Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Rating) CEO Mark J. Foley sold 31,279 shares of the firm’s stock in a transaction dated Friday, June 9th. The stock was sold at an average price of $30.72, for a total transaction of $960,890.88. Following the completion of the transaction, the chief executive officer now owns 891,933 shares […]

Related Keywords

Piper Sandler ,Markj Foley ,Ameriprise Financial Inc ,Castleark Management ,Centaurus Financial Inc ,Thrivent Financial For Lutherans ,International Biotechnology Trust ,Revance Therapeutics Inc ,Barclays ,Needham Company ,Nasdaq ,Revance Therapeutics ,Get Rating ,Biotechnology Trust ,Revance Therapeutics Daily ,